Pages Menu
Categories Menu

Posted by on Dec 9, 2015 in Foundation NewsLine |

ALERT: New Recruiting Sites for VTS-270 (2-hydroxypropyl-β-cyclodextrin) for NPC

ALERT: United States NPD Type C Families & Friends

The NNPDF central office noted today that additional investigational sites for Vtesse’s VTS-270 (2-hydroxypropyl-β-cyclodextrin) Phase 2b/3 clinical trial for NPC has been updated and is now actively recruiting patients at the approved clinical trial centers in Orange, CA & Allentown, PA.

Families should follow enrollment criteria as provided on the page. To view these criteria, location details and for additional contact information please visit and refer to study reference number: NCT02534844

For all previous updates regarding this clinical trial, visit the the links below:

Vtesse Phase 2b/3 Clinical Trial Historical Timeline can be viewed:
NIH Phase 1 Clinical Trial Historical Timeline can be viewed:



(function($) { function setup_collapsible_submenus() { var $menu = $('#category_mobile_menu'), top_level_link = '#category_mobile_menu .page_item_has_children > a'; $menu.find('a').each(function() { $(this).off('click'); if ( $(this).is(top_level_link) ) { $(this).attr('href', '#'); } if ( ! $(this).siblings('.children').length ) { $(this).on('click', function(event) { }); } else { $(this).on('click', function(event) { event.preventDefault(); $(this).parent().toggleClass('visible'); }); } }); } $(window).load(function() { setTimeout(function() { setup_collapsible_submenus(); }, 700); }); })(jQuery);